Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer

PURPOSE: Although increased plasma growth differentiation factor-15 (GDF15) levels have been reported in patients with various cancers, the predictive role of PD-1/PD-L1 inhibitors in advanced cancers remains unknown. This study aimed to investigate GDF15 levels as a predictive marker in advanced no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Green, Sun, Pureum, Chung, Chaeuk, Park, Dongil, Lee, Song-I, Kim, Nayoung, Lee, Seong Eun, Lee, Jeong Eun, Kang, Yea Eun, Kang, Da Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889409/
https://www.ncbi.nlm.nih.gov/pubmed/36472770
http://dx.doi.org/10.1007/s00432-022-04500-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889409/
https://www.ncbi.nlm.nih.gov/pubmed/36472770
http://dx.doi.org/10.1007/s00432-022-04500-5

Ejemplares similares